# MBX Biosciences, Inc. Common Stock (MBX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/mbx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering from chronic hypoparathyroidism. The company is also progressing with MBX 1416, a prolonged-action glucagon-like peptide-1 (GLP-1) receptor antagonist, which is undergoing Phase 1...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $50.46 USD |
| Market Cap | $2.43B |
| P/E (TTM) | — |
| EPS (TTM) | −$2.41 |
| 52-Week Range | $14.61 – $72.64 |
| Dividend Yield (TTM) | — |

## Dividend

MBX has no dividend payment history in our records.

## Frequently Asked Questions

### What does MBX Biosciences, Inc. Common Stock do?

MBX Biosciences, Inc. Common Stock (MBX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is MBX's market cap?

MBX Biosciences, Inc. Common Stock (MBX) has a market capitalization of approximately $2.43 billion, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does MBX pay a dividend?

No, MBX Biosciences, Inc. Common Stock (MBX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is MBX profitable?

MBX Biosciences, Inc. Common Stock (MBX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has MBX ever paid a dividend?

No. Dividend Data's records show no dividend payments from MBX Biosciences, Inc. Common Stock (MBX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/mbx
- Dividend history & safety: https://www.dividenddata.com/stocks/mbx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/mbx/earnings
- Financial statements: https://www.dividenddata.com/stocks/mbx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/mbx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/mbx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.